Nitric oxide regulation of myocardial O2 consumption and HEP metabolism

Jianyi Zhang, Guangrong Gong, Yun Ye, Tao Guo, Abdul Mansoor, Qingsong Hu, Koichi Ochiai, Jingbo Liu, Xiaohong Wang, Yarong Cheng, Nicole Iverson, Joseph Lee, Arthur H.L. From, Kamil Ugurbil, Robert J. Bache

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

NO and O2 compete at cytochrome-c oxidase, thus potentially allowing NO to modulate mitochondrial respiration. We previously observed a decrease of myocardial phosphocreatine (PCr)/ATP during very high cardiac work states, corresponding to an increase in cytosolic free ADP. This study tested the hypothesis that NO inhibition of respiration contributes to this increase of ADP. Infusion of dobutamine + dopamine (DbDp, each 20 μg·kg -1·min-1 iv) to more than double myocardial oxygen consumption (MV̇O2) in open-chest dogs caused a decrease of myocardial PCr/ATP measured with 31P NMR from 2.04 ± 0.09 to 1.85 ± 0.08 (P < 0.05). Inhibition of NO synthesis with N ω-nitro-L-arginine (L-NNA), while catecholamine infusion continued, caused PCr/ATP to increase to the control value. In a second group of animals, L-NNA administered before catecholamine stimulation (reverse intervention of the first group) increased PCr/ATP during basal conditions. In these animals L-NNA did not prevent a decrease of PCr/ATP at the high cardiac work state but, relative to MV̇O2, PCr/ATP was significantly higher after L-NNA. In a third group of animals, pharmacological coronary vasodilation with carbochromen was used to prevent changes in coronary flow that might alter endothelial NO production. In these animals L-NNA again restored depressed myocardial PCr/ATP during catecholamine infusion. The finding that inhibition of NO production increased PCr/ATP suggests that during very high work states NO inhibition of mitochondrial respiration requires ADP to increase to drive oxidative phosphorylation.

Original languageEnglish (US)
Pages (from-to)H310-H316
JournalAmerican Journal of Physiology - Heart and Circulatory Physiology
Volume288
Issue number1 57-1
DOIs
StatePublished - Jan 1 2005

Fingerprint

Phosphocreatine
Nitric Oxide
Adenosine Triphosphate
Adenosine Diphosphate
Catecholamines
Respiration
Chromonar
Dobutamine
Oxidative Phosphorylation
Electron Transport Complex IV
Vasodilation
Oxygen Consumption
Arginine
Dopamine
Thorax
Pharmacology
Dogs

Keywords

  • Heart
  • High-energy phosphate
  • Myocardial blood flow
  • Nuclear magnetic resonance spectroscopy
  • Phosphate

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Cite this

Nitric oxide regulation of myocardial O2 consumption and HEP metabolism. / Zhang, Jianyi; Gong, Guangrong; Ye, Yun; Guo, Tao; Mansoor, Abdul; Hu, Qingsong; Ochiai, Koichi; Liu, Jingbo; Wang, Xiaohong; Cheng, Yarong; Iverson, Nicole; Lee, Joseph; From, Arthur H.L.; Ugurbil, Kamil; Bache, Robert J.

In: American Journal of Physiology - Heart and Circulatory Physiology, Vol. 288, No. 1 57-1, 01.01.2005, p. H310-H316.

Research output: Contribution to journalArticle

Zhang, J, Gong, G, Ye, Y, Guo, T, Mansoor, A, Hu, Q, Ochiai, K, Liu, J, Wang, X, Cheng, Y, Iverson, N, Lee, J, From, AHL, Ugurbil, K & Bache, RJ 2005, 'Nitric oxide regulation of myocardial O2 consumption and HEP metabolism', American Journal of Physiology - Heart and Circulatory Physiology, vol. 288, no. 1 57-1, pp. H310-H316. https://doi.org/10.1152/ajpheart.00518.2004
Zhang, Jianyi ; Gong, Guangrong ; Ye, Yun ; Guo, Tao ; Mansoor, Abdul ; Hu, Qingsong ; Ochiai, Koichi ; Liu, Jingbo ; Wang, Xiaohong ; Cheng, Yarong ; Iverson, Nicole ; Lee, Joseph ; From, Arthur H.L. ; Ugurbil, Kamil ; Bache, Robert J. / Nitric oxide regulation of myocardial O2 consumption and HEP metabolism. In: American Journal of Physiology - Heart and Circulatory Physiology. 2005 ; Vol. 288, No. 1 57-1. pp. H310-H316.
@article{342504825aa849b181ca492c5b9a6db3,
title = "Nitric oxide regulation of myocardial O2 consumption and HEP metabolism",
abstract = "NO and O2 compete at cytochrome-c oxidase, thus potentially allowing NO to modulate mitochondrial respiration. We previously observed a decrease of myocardial phosphocreatine (PCr)/ATP during very high cardiac work states, corresponding to an increase in cytosolic free ADP. This study tested the hypothesis that NO inhibition of respiration contributes to this increase of ADP. Infusion of dobutamine + dopamine (DbDp, each 20 μg·kg -1·min-1 iv) to more than double myocardial oxygen consumption (MV̇O2) in open-chest dogs caused a decrease of myocardial PCr/ATP measured with 31P NMR from 2.04 ± 0.09 to 1.85 ± 0.08 (P < 0.05). Inhibition of NO synthesis with N ω-nitro-L-arginine (L-NNA), while catecholamine infusion continued, caused PCr/ATP to increase to the control value. In a second group of animals, L-NNA administered before catecholamine stimulation (reverse intervention of the first group) increased PCr/ATP during basal conditions. In these animals L-NNA did not prevent a decrease of PCr/ATP at the high cardiac work state but, relative to MV̇O2, PCr/ATP was significantly higher after L-NNA. In a third group of animals, pharmacological coronary vasodilation with carbochromen was used to prevent changes in coronary flow that might alter endothelial NO production. In these animals L-NNA again restored depressed myocardial PCr/ATP during catecholamine infusion. The finding that inhibition of NO production increased PCr/ATP suggests that during very high work states NO inhibition of mitochondrial respiration requires ADP to increase to drive oxidative phosphorylation.",
keywords = "Heart, High-energy phosphate, Myocardial blood flow, Nuclear magnetic resonance spectroscopy, Phosphate",
author = "Jianyi Zhang and Guangrong Gong and Yun Ye and Tao Guo and Abdul Mansoor and Qingsong Hu and Koichi Ochiai and Jingbo Liu and Xiaohong Wang and Yarong Cheng and Nicole Iverson and Joseph Lee and From, {Arthur H.L.} and Kamil Ugurbil and Bache, {Robert J.}",
year = "2005",
month = "1",
day = "1",
doi = "10.1152/ajpheart.00518.2004",
language = "English (US)",
volume = "288",
pages = "H310--H316",
journal = "American Journal of Physiology - Renal Physiology",
issn = "0363-6127",
publisher = "American Physiological Society",
number = "1 57-1",

}

TY - JOUR

T1 - Nitric oxide regulation of myocardial O2 consumption and HEP metabolism

AU - Zhang, Jianyi

AU - Gong, Guangrong

AU - Ye, Yun

AU - Guo, Tao

AU - Mansoor, Abdul

AU - Hu, Qingsong

AU - Ochiai, Koichi

AU - Liu, Jingbo

AU - Wang, Xiaohong

AU - Cheng, Yarong

AU - Iverson, Nicole

AU - Lee, Joseph

AU - From, Arthur H.L.

AU - Ugurbil, Kamil

AU - Bache, Robert J.

PY - 2005/1/1

Y1 - 2005/1/1

N2 - NO and O2 compete at cytochrome-c oxidase, thus potentially allowing NO to modulate mitochondrial respiration. We previously observed a decrease of myocardial phosphocreatine (PCr)/ATP during very high cardiac work states, corresponding to an increase in cytosolic free ADP. This study tested the hypothesis that NO inhibition of respiration contributes to this increase of ADP. Infusion of dobutamine + dopamine (DbDp, each 20 μg·kg -1·min-1 iv) to more than double myocardial oxygen consumption (MV̇O2) in open-chest dogs caused a decrease of myocardial PCr/ATP measured with 31P NMR from 2.04 ± 0.09 to 1.85 ± 0.08 (P < 0.05). Inhibition of NO synthesis with N ω-nitro-L-arginine (L-NNA), while catecholamine infusion continued, caused PCr/ATP to increase to the control value. In a second group of animals, L-NNA administered before catecholamine stimulation (reverse intervention of the first group) increased PCr/ATP during basal conditions. In these animals L-NNA did not prevent a decrease of PCr/ATP at the high cardiac work state but, relative to MV̇O2, PCr/ATP was significantly higher after L-NNA. In a third group of animals, pharmacological coronary vasodilation with carbochromen was used to prevent changes in coronary flow that might alter endothelial NO production. In these animals L-NNA again restored depressed myocardial PCr/ATP during catecholamine infusion. The finding that inhibition of NO production increased PCr/ATP suggests that during very high work states NO inhibition of mitochondrial respiration requires ADP to increase to drive oxidative phosphorylation.

AB - NO and O2 compete at cytochrome-c oxidase, thus potentially allowing NO to modulate mitochondrial respiration. We previously observed a decrease of myocardial phosphocreatine (PCr)/ATP during very high cardiac work states, corresponding to an increase in cytosolic free ADP. This study tested the hypothesis that NO inhibition of respiration contributes to this increase of ADP. Infusion of dobutamine + dopamine (DbDp, each 20 μg·kg -1·min-1 iv) to more than double myocardial oxygen consumption (MV̇O2) in open-chest dogs caused a decrease of myocardial PCr/ATP measured with 31P NMR from 2.04 ± 0.09 to 1.85 ± 0.08 (P < 0.05). Inhibition of NO synthesis with N ω-nitro-L-arginine (L-NNA), while catecholamine infusion continued, caused PCr/ATP to increase to the control value. In a second group of animals, L-NNA administered before catecholamine stimulation (reverse intervention of the first group) increased PCr/ATP during basal conditions. In these animals L-NNA did not prevent a decrease of PCr/ATP at the high cardiac work state but, relative to MV̇O2, PCr/ATP was significantly higher after L-NNA. In a third group of animals, pharmacological coronary vasodilation with carbochromen was used to prevent changes in coronary flow that might alter endothelial NO production. In these animals L-NNA again restored depressed myocardial PCr/ATP during catecholamine infusion. The finding that inhibition of NO production increased PCr/ATP suggests that during very high work states NO inhibition of mitochondrial respiration requires ADP to increase to drive oxidative phosphorylation.

KW - Heart

KW - High-energy phosphate

KW - Myocardial blood flow

KW - Nuclear magnetic resonance spectroscopy

KW - Phosphate

UR - http://www.scopus.com/inward/record.url?scp=19944422074&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=19944422074&partnerID=8YFLogxK

U2 - 10.1152/ajpheart.00518.2004

DO - 10.1152/ajpheart.00518.2004

M3 - Article

C2 - 15374825

AN - SCOPUS:19944422074

VL - 288

SP - H310-H316

JO - American Journal of Physiology - Renal Physiology

JF - American Journal of Physiology - Renal Physiology

SN - 0363-6127

IS - 1 57-1

ER -